Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

Kate Moss's daughter Lila launches first ever Barbie doll with type 1 diabetes

Fashion for some will always come first but by introducing the first Barbie doll with type 1 diabetes, Mattel are showing, once again, that the world of child's play can be a space for the true representation of different social groups.

Euronews

Why Mattel Created a Type 1 Diabetes Barbie Doll: A Focus On The Growing Health Crisis Among Young Girls

Barbie now reflects real-life conditions. Mattel releases a Type 1 diabetes doll amid rising cases among UK girls and calls for inclusive representation.

International Business Times UK

Barbie Launches First-Ever Type 1 Diabetes Doll, Honors Latina Fitness Star Robin Arzón

Mattel has unveiled the first-ever Barbie doll with Type 1 diabetes, joining its Barbie Fashionistas line in a groundbreaking move toward better representation for children managing chronic health conditions.

Latin Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Kate Moss’s daughter Lila launches first Barbie doll with type one diabetes

The diabetes doll is released on Wednesday and priced at £13.99.

Evening Standard

Barbie launches first doll with Type 1 diabetes that comes with pink glucose monitor

Kate Moss’s daughter Lila Moss says the launch of the first Barbie doll with type 1 diabetes is ‘completely surreal’

The Independent UK

‘Representation matters’: Barbie launches first doll with type 1 diabetes

Doll with insulin pump and glucose monitor is latest in range designed ‘to enable more children to see themselves’

The Guardian - UK

New therapy teplizumab could delay type 1 diabetes by years – if caught early

For more than a century, type 1 diabetes has meant one thing: a lifetime administering insulin. But for the first time, science is breaking that paradigm – not by managing the disease, but by intercepting it before symptoms even appear.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Drug breakthrough for patients with type 1 diabetes

IN FULL

The Independent UK

Persistent and widespread medicine shortages putting patients at risk

The ‘severe, persistent, and disruptive’ shortages often impact patients with ADHD, menopause and diabetes, a new report says

The Independent UK

‘Groundbreaking’ drug could slow progression of type 1 diabetes

A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS.

Evening Standard

Mother of two becomes first UK patient to receive ‘groundbreaking’ new diabetes drug

New drug offers future hope that people with type 1 diabetes will not need to take insulin

The Independent UK

Medicine shortages put patients at risk, MPs and peers warn

The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes.

Evening Standard

Ageing isn’t the same everywhere – why inflammation may be a lifestyle problem

For years, scientists have believed that inflammation inevitably increases with age, quietly fuelling diseases like heart disease, dementia and diabetes. But a new study of Indigenous populations challenges that idea and could reshape how we think about ageing itself.

The Conversation

Vital steps to move the NHS from cure to prevention

Letters: Readers respond to Guardian coverage of health inequalities in Britain and the government’s 10-year plan for the health service

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Your holiday cookout could be killing you

New study builds on years of research tying processed foods to higher risks of obesity, heart disease, diabetes, and cancer.

LiveScience

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with type 1 diabetes.

Euronews

Eating lots of red meat, other inflammatory foods during pregnancy raises risk of childhood diabetes

The study indicates that women’s diets may have long-lasting effects on their children’s health.

The Conversation

The rising rate of type 2 diabetes in young New Zealanders is becoming a health crisis

No longer just a condition of middle age, type 2 diabetes is increasingly affecting children, teenagers and young adults in New Zealand. And our health system is nowhere near ready to manage this surge.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Triple threat of smoking, drinking and weight ‘puts a million in England at risk of early death’

Exclusive: Three risky behaviours can mean people dying 20 years earlier than they should, says senior doctor

The Guardian - UK

Hundreds of weight loss and diabetes jab users report pancreas problems

UK health officials launch study into side-effects of weight loss drugs after increased reports of acute pancreatitis

The Conversation

People with severe diabetes cured in small stem cell trial

The cure for diabetes is a life free from daily insulin injections. Based on that criterion, ten out of 12 people (83%) in a new clinical trial were cured of their diabetes one year after receiving an advanced stem cell therapy.

The Independent UK

‘Holy grail’ diet pill burns fat without affecting appetite or muscle mass unlike weight loss jabs

This new pill works by triggering the metabolism in the muscles, activating them to burn more fat, without the gastrointestinal side effects of weight loss jabs

The Independent UK

Mounjaro on the NHS: Expert advice on what you need to know

Mounjaro has been approved for both type 2 diabetes and weight loss, but access will be limited by strict eligibility criteria

Barchart

How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?

Insulet has outperformed the Medical Devices industry over the past year, and analysts are highly optimistic about the stock’s prospects.

The Independent UK

Mounjaro is available on the NHS. Here’s what to do if you’re not eligible

Mounjaro has been approved for both type 2 diabetes and weight loss; however, access will be limited by strict eligibility criteria

1 … 17 18 19 20

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Exeter

Karolinska Institutet

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.